Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder CarcinomaEmil Christensen, Lars Dyrskjøt, Hsin-Ta Wu et al.|Journal of Clinical Oncology|2019Cited by 540
Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy AnalysisKarin Birkenkamp‐Demtröder, Lars Dyrskjøt, Emil Christensen et al.|European Urology|2017Cited by 176
Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder CancerEmil Christensen, Lars Dyrskjøt, Iver Nordentoft et al.|Clinical Cancer Research|2023Cited by 73